AllianceBernstein’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,443
| Closed | -$38.8K | – | 3277 |
|
|
2023
Q1 | $38.8K | Hold |
1,443
| – | – | ﹤0.01% | 3107 |
|
|
2022
Q4 | $51.1K | Buy |
1,443
+243
| +20% | +$8.6K | ﹤0.01% | 3172 |
|
|
2022
Q3 | $271K | Buy |
1,200
+93
| +8% | +$21K | ﹤0.01% | 2903 |
|
|
2022
Q2 | $209K | Buy |
1,107
+127
| +13% | +$24K | ﹤0.01% | 3008 |
|
|
2022
Q1 | $244K | Hold |
980
| – | – | ﹤0.01% | 2932 |
|
|
2021
Q4 | $153K | Sell |
980
-63
| -6% | -$9.84K | ﹤0.01% | 3123 |
|
|
2021
Q3 | $209K | Hold |
1,043
| – | – | ﹤0.01% | 3068 |
|
|
2021
Q2 | $267K | Buy |
1,043
+43
| +4% | +$11K | ﹤0.01% | 3047 |
|
|
2021
Q1 | $266K | Hold |
1,000
| – | – | ﹤0.01% | 2944 |
|
|
2020
Q4 | $369K | Hold |
1,000
| – | – | ﹤0.01% | 2738 |
|
|
2020
Q3 | $244K | Hold |
1,000
| – | – | ﹤0.01% | 2897 |
|
|
2020
Q2 | $288K | Buy |
1,000
+357
| +56% | +$103K | ﹤0.01% | 2880 |
|
|
2020
Q1 | $131K | Buy |
643
+300
| +87% | +$61.1K | ﹤0.01% | 2898 |
|
|
2019
Q4 | $153K | Hold |
343
| – | – | ﹤0.01% | 2970 |
|
|
2019
Q3 | $106K | Buy |
+343
| New | +$106K | ﹤0.01% | 3062 |
|